SCHEMBL7144004

SCHEMBL7144004

CC(C)CCN(C1(C(=O)NO)CC2OCOC2C1)S(=O)(=O)c1ccc(OCCc2ccncc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MMP3 P08254 6/20 0.42
▸ ADAM17 P78536 6/20 0.40
▸ MMP1 P03956 4/20 0.38
▸ ACACB O00763 1/20 0.38
▸ MMP13 P45452 5/20 0.37
▸ MMP2 P08253 4/20 0.37
▸ MMP9 P14780 2/20 0.37
▸ MMP14 P50281 2/20 0.36
▸ ADAMTS4 O75173 1/20 0.36
▸ ADAMTS5 Q9UNA0 1/20 0.36
▸ ADAM10 O14672 1/20 0.36
▸ MMP7 P09237 1/20 0.36
▸ MMP8 P22894 1/20 0.36
▸ MMP12 P39900 1/20 0.36
▸ ADAM9 Q13443 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139241 0.83 MMP1 (0.57) MMP3ADAM17MMP1MMP13MMP2
SCHEMBL7141116 0.77 MMP1 (0.51) MMP3ADAM17MMP1MMP13MMP2
SCHEMBL7134744 0.77 MMP2 (0.49) MMP3ADAM17MMP1ACACBMMP13
SCHEMBL7136841 0.76 MMP1 (0.50) MMP3MMP1MMP13MMP2MMP9
SCHEMBL7140995 0.74 MMP1 (0.61) MMP3ADAM17MMP1MMP13MMP2
SCHEMBL7135520 0.72 MMP1 (0.49) MMP3ADAM17MMP1MMP13MMP2
SCHEMBL7140315 0.72 MMP1 (0.49) MMP3ADAM17MMP1MMP13MMP2
SCHEMBL7143794 0.71 MMP1 (0.73) MMP3MMP1MMP13MMP2MMP9
SCHEMBL7330071 0.70 MMP1 (0.59) MMP3ADAM17MMP1MMP13MMP2
SCHEMBL7141637 0.69 MMP1 (0.54) MMP3ADAM17MMP1MMP13MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1041072-B1 Dioxocyclopentyl hydroxamic acids PFIZER PROD INC (US) 2003-07-16 — — EP disclosed
US-6214870-B1 ANTIARTHRITIC AGENTS; ANTICANCER AGENTS PFIZER INC 2001-04-10 — — US disclosed
EP-1041072-A1 Dioxocyclopentyl hydroxamic acids Pfizer Products Inc. (US) 2000-10-04 — — EP disclosed
Send feedback